119-OR: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Ultra-Long-Acting GLP-1 Receptor Agonist (ZT002) in Healthy Subjects
用户aKgJC6g3RnhA
5个月前
271
10
已完结
1. 系统已在2025-05-07 15:07:36对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.2337/db24-119-or
其他信息:
出版社: American Diabetes Association
作者: YUANYUAN ZHANG; XIUSEN XU; KRISTI MCLENDON; ALEX H.L. WONG; YUYING ZHANG; XUJIA ZHANG
全文下载地址: https://diabetesjournals.org/diabetes/article/73/Supplement_1/119-OR/155504/119-OR-Safety-Tolerability-Pharmacokinetics-and
